<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10582</article-id><article-id pub-id-type="doi">10.32607/20758251-2013-5-4-110-117</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Research Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Экспериментальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Three-Dimensional Model of Mouse Epidermis for Experimental Studies of Psoriasis</article-title><trans-title-group xml:lang="ru"><trans-title>Трехмерная модель мышиного эпидермиса для лабораторных исследований псориаза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Soboleva</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Соболева</surname><given-names>A. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mesentsev@vigg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sobolev</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Соболев</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mesentsev@vigg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bruskin</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Брускин</surname><given-names>С. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mesentsev@vigg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mezentsev</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Мезенцев</surname><given-names>A. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mesentsev@vigg.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Non-profit Research Institute of Russian Academy of Sciences, N.I. Vavilov Institute of General Genetics</institution></aff><aff><institution xml:lang="ru">Институт общей генетики им. Н.И. Вавилова РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2013</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en">VOL 5, NO4 (2013)</issue-title><issue-title xml:lang="ru">ТОМ 5, №4 (2013)</issue-title><fpage>110</fpage><lpage>117</lpage><history><date date-type="received" iso-8601-date="2020-01-17"><day>17</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Soboleva A.G., Sobolev V.V., Bruskin S.A., Mezentsev A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, Соболева A.Г., Соболев В.В., Брускин С.A., Мезенцев A.В.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Soboleva A.G., Sobolev V.V., Bruskin S.A., Mezentsev A.V.</copyright-holder><copyright-holder xml:lang="ru">Соболева A.Г., Соболев В.В., Брускин С.A., Мезенцев A.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/10582">https://actanaturae.ru/2075-8251/article/view/10582</self-uri><abstract xml:lang="en"><p>Three-dimensional models of skin and epidermis imitate the structure of real tissues and provide accurate information about certain skin conditions, such as psoriasis. A three-dimensional model of mouse epidermis was generated from the epidermal keratinocytes of newborn mice and treated with cytokines. The aim of this study was to evaluate this model as an experimental model of psoriasis and to assess the changes occurring in its structure and gene expression after the exposure to proinflammatory cytokines. Treatment of the three-dimensional model with either interleukin 17 or a combination of tumor necrosis factor and interferon γ was shown to produce morphological changes, which were similar to acanthosis in psoriatic skin. The observed changes in gene expression of metalloproteinases and certain psoriasis biomarkers, such as mki67, krt16 and fosl1, were similar to the changes in patients’ skin. Notably, changes caused by interleukin 17 were less evident than those caused by the combination of interferon γ and tumor necrosis factor. On the contrary, HaCaT cells exhibited no significant changes in the expression of fosl1 and had decreased levels of mki67 after being treated with a combination of TNF and IFNG. Moreover, treatment with IL17 had no significant effect on krt16 and mki67 expression and even reduced the fosl1 levels. The findings suggest that artificially generated three-dimensional models of murine skin can be used to study psoriasis.</p></abstract><trans-abstract xml:lang="ru"><p>Трехмерные модели кожи и эпидермиса позволяют получать достоверную информацию о таких заболеваниях, как псориаз, поскольку они точно имитируют структуру кожи. Из кератиноцитов новорожденных мышат нами получена трехмерная модель эпидермиса, которую обработали цитокинами. В представленной работе оценена пригодность этой трехмерной модели для изучения псориаза, описаны изменения в ее структуре и экспрессии генов после обработки провоспалительными цитокинами. Показано, что обработка трехмерной модели интерлейкином 17 или комбинацией фактора некроза опухолей и интерферона γ приводит к изменениям структуры, сходным с проявлениями акантоза при псориазе. Наблюдаемые изменения в экспрессии генов металлопротеиназ и других биомаркеров псориаза (mki67, krt16 и fosl1) были сходны с изменениями в пораженной коже больных. Обработка модели интерфероном γ и фактором некроза опухолей приводит к более выраженным изменениям экспрессии генов, чем обработка интерлейкином 17. Напротив, обработка клеток HaCaT фактором некроза опухолей и интерфероном γ не влияла существенно на экспрессию fosl1, но снижала экспрессию mki67, интерлейкин 17 практически не влиял на экспрессию krt16 и mki67, но снижал экспрессию fosl1. Результаты исследования подтверждают возможность использования трехмерной модели эпидермиса мыши для изучения псориаза.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acanthosis</kwd><kwd>cell culturing</kwd><kwd>psoriasis</kwd><kwd>cornification</kwd><kwd>qPCR</kwd><kwd>three-dimensional modeling</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>акантоз</kwd><kwd>количественная ПЦР</kwd><kwd>корнификация</kwd><kwd>культивирование клеток</kwd><kwd>псориаз</kwd><kwd>трехмерное моделирование</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This work was supported by the Ministry of Science and Education of the Russian Federation (grant No. 16.512.11.2049), the federal program “From Fundamental Science to Medicine” and the special program “Scientific and Pedagogical Potential of Innovative Russia” (grant No. P1309).</funding-statement><funding-statement xml:lang="ru">Работа поддержана Министерством науки и образования Российской Федерации (грант № 16.512.11.2049), федеральной программой «От фундаментальной науки к медицине» и специальной программой «Научный и педагогический потенциал инновационной России» (грант № P1309).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>[1] Kolbe L., Mann T., Gerwat W., Batzer J., Ahlheit S., Scherner C., Wenck H., Stab F. // J. Eur. Acad. Dermatol. Venerol. 2013, V.27, S1, P.19-23</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>[2] Vasil’ev A.V., Vorotelyak E.A., Kisilev I.V., Terskikh V.V. // Vestn. Ross. akad. med. nauk (Annals of the Russian Academy of Medical Sciences). 2008, №2, P.45-53</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>[3] Mel’tsova A.Zh., Gritsenko V.V., Orlovskiy P.I., Tomson V.V., Sabel’nikov V.V., Shulepova E.K., Prokopets A.I., Pinaev G.P., Blinova M.I., Iudintseva N.M. // Vestn. Khir. Im. I. I. Grek. 2007, V.166, №1, P.72-77</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>[4] Kandarova H., Liebsch M., Genschow E., Gerner I., Traue D., Slawik B., Spielmann H. // Altex. 2004, V.21, №3, P.107-114</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>[5] Mun G.C., Aardema M.J., Hu T., Barnett B., Kaluzhny Y., Klausner M., Karetsky V., Dahl E.L., Curren R.D. // Mutat. Res. 2009, V.673, №2, P.92-99</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>[6] Johnson-Huang L.M., Lowes M.A., Krueger J.G. // Dis. Model Mech. 2012, V.5, №4, P.423-433</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>[7] Tjabringa G., Bergers M., van Rens D., de Boer R., Lamme E., Schalkwijk J. // Am. J. Pathol. 2008, V.173, №3, P.815-823</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>[8] Chomczynski P., Mackey K. // BioTechniques 1995, V.19, №6, P.942-945</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>[9] Starodubtseva N.L., Sobolev V.V., Soboleva A.G., Nikolaev A.A., Bruskin S.A. // Genetika. 2011, V.47, №9, P.1117-1123</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>[10] Starodubtseva N.L., Minnibaev M.T., Soboleva A.G., Korsunskaya I.M., Krivoshchapov L.G., Elkin A.M., Iakovenko G.T., Piruzyan A.L., Bruskin S.A., Sobolev V.V. // Sovremennye problemy dermatovenerologii, immunologii i vrachebnoy kosmetologii (Modern problems of dermatovenereology, immunology, and clinical cosmetology). 2011, V.2, №15, P.38-41</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>[11] Smirnov S.V., Kiselev I.V., Vasil’ev A.V., Terskikh V.V. // Khirurgiia (Mosk). 2003, №12, P.58-62</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>[12] Panarin E.F., Nud’ga P.A., Petrova V.A., Bochek A.M., Goffman I.V., Baklagina Yu.G., Saprykina N.N., Blinova M.I., Yudintseva N.M., Spichkina O.G. // Cellular transplantology and tissue engineering. 2010, V.5, №1, P.65-73</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>[13] Shved Yu.A., Kukhareva L.V., Zorin I.M., Solov’ev A.Iu., Blinova M.I., Bilibin A.Iu., Pinaev G.P. // Tsitologiia. 2006, V.48, №2, P.161-168</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>[14] Shved Yu.A., Zorin I.M., Pinaev G.P., Bilibin A.Iu. // Fisiko-khimia polimerov: sintez, svoystva i primenenie (Physical chemistry of polymers: synthesis, properties and applications). 2009, №15, P.175-179</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>[15] Linde N., Gutschalk C.M., Hoffmann C., Yilmaz D., Mueller M.M. // PloS One. 2012, V.7, №7, P.e40058</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>[16] Souto L.R., Vassallo J., Rehder J., Pinto G.A., Puzzi M.B. // Sao Paulo Med. J. 2009, V.127, №1, P.28-33</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>[17] Uchino T., Takezawa T., Ikarashi Y. // Toxicol. in vitro. 2009, V.23, №2, P.333-337</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>[18] Nakajima K., Kanda T., Takaishi M., Shiga T., Miyoshi K., Nakajima H., Kamijima R., Tarutani M., Benson J.M., Elloso M.M. // J. Immunol. 2011, V.186, №7, P.4481-4489</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>[19] Schonthaler H.B., Huggenberger R., Wculek S.K., Detmar M., Wagner E.F. // Proc. Natl. Acad. Sci. USA. 2009, V.106, №50, P.21264-21269</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>[20] Liang Y. // Patholog. Res. Int. 2011, №936794</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>[21] Wang Z., Sokolovska A., Seymour R., Sundberg J.P., Hogenesch H. // PloS One. 2012, V.7, №2, P.e31809</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>[22] van der Fits L., Mourits S., Voerman J.S., Kant M., Boon L., Laman J.D., Cornelissen F., Mus A.M., Florencia E., Prens E.P. // J. Immunol. 2009, V.182, №9, P.5836-5845</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>[23] Fransson J., Hammar H. // Arch. Dermatol. Res. 1992, V.284, №6, P.343-348</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>[24] Rikimaru K., Moles J.P., Watt F.M. // Exp. Dermatol. 1997, V.6, №5, P.214-221</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>[25] Iizuka H., Takahashi H., Honma M., Ishida-Yamamoto A. // J. Dermatol. 2004, V.31, №4, P.271-276</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>[26] Serov D.N., Sobolev V.V., Potekaev N.N., Piruzian E.S., Korsunskaya I.M., Abdeeva I.A., Soboleva A.G., Zolotarenko A.D., Minnibaev M.T. // Klinicheskaia dermatologia i venerologia (Clinical dermatology and venereology). 2010, №4, P.4-9</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>[27] Balbin M., Fueyo A., Knauper V., Lopez J. M., Alvarez J., Sanchez L.M., Quesada V., Bordallo J., Murphy G., Lopez-Otin C. // J. Biol. Chem. 2001, V.276, №13, P.10253-10262</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>[28] Hyc A., Osiecka-Iwan A., Niderla-Bielinska J., Moskalewski S. // Int. J. Mol. Med. 2011, V.27, №1, P.127-137</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>[29] Huang Y.C., Wang T.W., Sun J.S., Lin F.H. // Artif. Organs. 2006, V.30, №3, P.150-159</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>[30] Li Z., Rana T.M. // Nat. Commun. 2012, V.3, P.1085</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>[31] Yano S., Banno T., Walsh R., Blumenberg M. // J. Cell. Physiol. 2008, V.214, №1, P.1-13</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>[32] Gazel A., Rosdy M., Bertino B., Tornier C., Sahuc F., Blumenberg M. // J. Invest. Dermatol. 2006, V.126, №12, P.2647-2657</mixed-citation></ref></ref-list></back></article>
